Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Sanofi    SAN   FR0000120578

SANOFI (SAN)

Delayed Quote. Delayed  - 01/16 05:39:48 pm
76.81 EUR   -1.61%
06:54p SANOFI : Disclosure of trading in own shares
06:54p SANOFI : Disclosure of trading in own shares
01/10 SANOFI : Sedalia losing a mile of the Katy Trail
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Sanofi
Engages in the research, production and distribution of pharmaceutical products

Sanofi engages in the research, production and distribution of pharmaceutical products.

It operates through the following segments: Pharmaceuticals, Human Vaccines, and Animal Health.

The Pharmaceuticals segment includes research, development, production and sales activities relating to pharmaceutical products, including prescription, consumer health care, and generic products.

This segment also includes equity affiliates and joint ventures with pharmaceutical business activities.

The Human Vaccines segment includes research, development, production and marketing of vaccines.

The Animal Health segment comprises the research, development, production and marketing activities for Merial, which offers a range of medicines and vaccines for animal species.

The company was founded on April 28, 1994 and is headquartered in Paris, France.

Number of employees : 115 631 persons.
Sales per Businesses
20142015Delta
EUR (in Million)%EUR (in Million)%
Pharmaceuticals27,72082.1%29,79986.3% +7.5%
Vaccines3,97411.8%4,74313.7% +19.35%
Animal Health2,0766.1%---
Sales per Regions
20142015Delta
EUR (in Million)%EUR (in Million)%
United States11,33933.6%12,24635.5% +8%
Western Europe5,39116%5,24815.2% -2.65%
Latin America3,36310%3,0478.8% -9.4%
Asia (Excluding Pacific Region)3,2059.5%3,53610.2% +10.33%
Eastern Europe and Turkey2,5417.5%2,3666.8% -6.89%
France2,4747.3%2,2486.5% -9.14%
Japan2,1196.3%2,0345.9% -4.01%
Other1,1753.5%229.000.7% -80.51%
Rest of the World1,1003.3%1,3664% +24.18%
Middle East1,0633.1%---
Africa and Middle-East--2,2226.4%-
Managers
NameAgeSinceTitle
Olivier Brandicourt MD, PhD612015Chief Executive Officer & Director
Serge Weinberg662009Chairman
Jérôme Contamine602009Chief Financial Officer & EVP-Finance
Elias E. Zerhouni, MD662011President-Global Research & Development
Yong-Jun Liu MD, PhD-2016Head-Global Research & Development
Ameet Nathwani MD, MBA-2016Executive Vice President-Medical Affairs
Robert Castaigne, PhD712000Independent Director
Claudie Haigneré MD, PhD602008Independent Director
Carole Piwnica592010Independent Director
Suet-Fern Lee592011Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 1,287,105,713 1,156,997,968 89.9% 100,000 0.0% 89.9%
Shareholders
NameEquities%
L'Oréal SA 118,227,307 9.16%
Dodge & Cox 27,082,752 2.10%
Norges Bank Investment Management 26,541,076 2.06%
The Vanguard Group, Inc. 23,744,181 1.84%
Berkshire Hathaway, Inc. (Investment Management) 22,169,930 1.72%
Amundi Asset Management SA (Investment Management) 17,597,974 1.36%
Plan d'Epargne Entreprise Sanofi Synthelabo 16,697,049 1.29%
Lyxor International Asset Management SAS 13,299,250 1.03%
BlackRock Fund Advisors 12,939,252 1.00%
Natixis Asset Management SA 12,463,852 0.97%
Holdings
NameEquities%Valuation
Regeneron Pharmaceuticals Inc (REGN) 23,418,39622.6%8,596,658,988 USD
Aventis Pharma Limited (AVPH) 13,909,58760.4%880,605,799 USD
Alnylam Pharmaceuticals, Inc. (ALNY) 10,256,63312.0%384,008,340 USD
Sanofi (SAN) 3,956,7080.31%320,929,654 USD
Zentiva SA (ROSCD) 312,341,64974.9%141,422,052 USD
Myokardia Inc (MYOK) 3,668,89911.7%47,512,242 USD
Voyager Therapeutics Inc (VYGR) 2,477,9419.26%31,568,968 USD
Regulus Therapeutics Inc (RGLS) 5,053,7799.55%11,371,003 USD
Proteome Sciences plc (PRM) 0
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
SANOFI1.52%107 323
JOHNSON & JOHNSON-0.53%311 773
ROCHE HOLDING LTD.2.75%204 641
PFIZER INC.0.12%197 343
NOVARTIS AG-1.48%189 749
MERCK & CO., INC.5.89%171 880
GLAXOSMITHKLINE PLC1.50%94 828
BRISTOL-MYERS SQUIBB C..-3.80%93 957
BAYER AG2.54%89 438
ELI LILLY AND CO5.23%85 446
ALLERGAN PLC2.92%81 070
NOVO NORDISK A/S-1.73%72 097
ASTRAZENECA PLC3.86%70 916
ABBOTT LABORATORIES6.56%70 653
SHIRE PLC-0.48%51 258
TAKEDA PHARMACEUTICAL ..-0.35%33 647
ASTELLAS PHARMA INC-2.09%30 289
MYLAN NV-3.72%19 654
EISAI CO., LTD-2.10%17 174
CHUGAI PHARMACEUTICAL ..2.38%16 861
SHIONOGI & CO LTD-0.59%16 049
Sector Pharmaceuticals - NEC
Sanofi : Connections
54 rue la Boétie
FR-75008 Paris
France

Phone : +33 (0)1 53 77 40 00
Fax : +33 (0)1 53 77 44 63
Internet : http://www.sanofi.com
Markets and indexes
- PEA / SRD eligible : YES / YES
- Euronext Paris
- Compartiment A
- CAC 40 / CAC All Shares, CAC All-Tradable, CAC Large 60, Euronext 100, EuroStoxx 50, FTSE Eurotop 100, Low Carbon 100 Europe, PEA, Stoxx Europe 50, Stoxx France 50, Stoxx Global 200
Stock Exchange Codes
- ISIN Code :  FR0000120578
- Bloomberg Code :  SAN:FP
- Reuters Code :  SASY.PA
- Datastream Code :  F:SQ@F
© 2017 People , Fundamentals and Ownership    © 2017 Cofisem